Hypoalbuminaemia, systemic albumin leak and endothelial dysfunction in peritoneal dialysis patients
Open Access
- 19 April 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 27 (12), 4437-4445
- https://doi.org/10.1093/ndt/gfs075
Abstract
Inflammation, hypoalbuminaemia and peritoneal protein clearance are important predictors of survival in patients treated with peritoneal dialysis (PD). We hypothesized that the common link is abnormal endothelial barrier function. To test this, we explored associations between hypoalbuminaemia, systemic albumin leak and soluble markers of systemic inflammation and endothelial injury. This was a cross-sectional study of 41 prevalent PD patients. Endothelial barrier function was measured as transcapillary escape rate of 125I albumin [transcapillary escape rate of albumin (TERalb)]. Seventeen plasma biomarkers including pro-inflammatory cytokines, endothelial biomarkers and metalloproteinases were measured. Hierarchical clustering analysis (HCA) and principal component analysis (PCA) were used to explore the hypothesis. The mean TERalb was 13.7 ± 8.9 (%/h), higher than in non-uraemic subjects 8.22 ± 5.8 (%/h). Three patient clusters were defined from HCA according to their biomarker patterns. Cluster 1 was characterized by inflammation, hypoalbuminaemia, overhydration and intermediate TERalb. Cluster 2 was non-inflamed, preserved muscle mass and more normal TERalb. Cluster 3 had highest TERalb, platelet activation, preserved plasma albumin and intermediate high-sensitivity C-reactive protein levels. Two principal components (PCs) were identified from the biomarker matrix, PC1, indicating platelet activation and PC2, pro-inflammatory. TERalb was positively related to PC1 but not PC2. Diabetes and ischaemic heart disease were associated with PC1 and PC2, respectively. This exploratory analysis indicates that endothelial barrier function is decreased in PD patients and is associated with diabetic status and markers of platelet activation more than inflammation. In contrast, hypoalbuminaemia is associated more with inflammation and atherosclerotic disease indicating a more complex relationship between systemic endothelial barrier function, inflammation and hypoalbuminaemia which requires further validation.Keywords
This publication has 36 references indexed in Scilit:
- Serum Albumin as a Predictor of Mortality in Peritoneal Dialysis: Comparisons With HemodialysisAmerican Journal of Kidney Diseases, 2011
- Platelets, inflammation and tissue regenerationThrombosis and Haemostasis, 2011
- Plasma Volume, Albumin, and Fluid Status in Peritoneal Dialysis PatientsClinical Journal of the American Society of Nephrology, 2010
- Combining Near-Subject Absolute and Relative Measures of Longitudinal Hydration in HemodialysisClinical Journal of the American Society of Nephrology, 2009
- Peritoneal Protein Clearance and not Peritoneal Membrane Transport Status Predicts Survival in a Contemporary Cohort of Peritoneal Dialysis PatientsClinical Journal of the American Society of Nephrology, 2009
- Dynamics of neutrophil extravasation and vascular permeability are uncoupled during aseptic cutaneous woundingAmerican Journal of Physiology-Cell Physiology, 2009
- Emerging Biomarkers for Evaluating Cardiovascular Risk in the Chronic Kidney Disease PatientClinical Journal of the American Society of Nephrology, 2008
- Microalbuminuria and Transcapillary Albumin Leakage in Essential HypertensionHypertension, 1999
- Transvascular and Urinary Leakage of Albumin in Atherosclerotic and Hypertensive MenHypertension, 1998
- Renal and Systemic Transvascular Albumin Leakage in Severe AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 1995